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ing by ElAbstract Objective: The aim of this study was to evaluate the role of diffusion-weighted images
(DWI) in the differentiation between benign and malignant breast tumors.
Patients and methods: This study included 62 females with focal breast lesions according to mam-
mography or sonomamography. All patients underwent dynamic contrast enhanced MRI (DCE-
MRI), and DWI of the breast. The mean apparent diffusion coefﬁcient (ADC) values were calcu-
lated for all lesions and were correlated with the ﬁnal histopathological results. The sensitivity and
speciﬁcity of DWI in the differentiation between benign and malignant breast tumors were calcu-
lated.
Results: Seventy-eight lesions were detected in the examined 62 patients included in this study.
Fifty one lesions were benign and 27 lesions were malignant according to the ﬁnal histopathological
results. (25/27) lesions were correctly diagnosed by ADC as malignant lesions with mean ADC
value (0.92 ± 0.23 · 103 mm2/s) which was signiﬁcantly lower than the mean ADC value for
benign tumors (1.46 ± 0.48 · 103 mm2/s) and was correctly diagnosed in (50/51) lesions. The sen-
sitivity and speciﬁcity of DWI in the differentiation between benign and malignant breast tumors
were 92.6% and 98%, respectively.4038955.
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Table 1 Different ADC values for
Type of lesions No. of
ADC v
Benign 52
Malignant 26
Fibroglandular tissue 62*
* Number of normal examined patien
94 G.K. Gouhar, E.-S.H. ZidanConclusion: DWI offers a useful method for differentiation of benign and malignant breast lesions
with high sensitivity and speciﬁcity. Being a short unenhanced scan DWI can be safely added to the
standard breast MRI protocol.
 2011 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Dynamic contrast enhanced MRI (DCE-MRI) of the breast
has been widely used for the diagnosis and characterization
of breast lesions and it is a sensitive breast screening technique
for women at risk; also it can accurately delineate the extent of
the disease than mammography or sonomamography (1–3).
Speciﬁc patterns of enhancement known as time-signal
intensity curve (kinetic curve) has been proposed (4,5). These
patterns are classiﬁed as: type (I), persistent enhancement
(monotonic increase) and is suggestive of benign breast lesions,
type (II), plateau enhancement (constant level) and can be seen
in both benign and malignant lesions, type (III), washout
enhancement (initial peak followed by an immediate decrease
in the signal intensity) and is suggestive of malignant breast le-
sions (6).
DCE-MRI has a sensitivity of about 85–99%, and a lower
speciﬁcity of about 40–80% in detecting breast lesions; this
lowered speciﬁcity is believed to be due to menstrual cycle,
hormonal replacement therapy and proliferative alterations
(7,8).
DWI is an unenhanced MRI sequences that measures the
mobility of water molecules in vivo which has a potential role
in characterizing breast lesions (9,10). The apparent diffusion
coefﬁcient (ADC) value is an effective parameter for distin-
guishing between benign and malignant breast lesions, because
tumor cellularity has a signiﬁcant inﬂuence on ADC values
(11,12). The high cellular density in the malignant lesions
causes restriction of the extracellular matrix, and increased
fraction of signal coming from intracellular water, this result-
ing in a lower ADC values in the malignant lesions (13–15).
The aim of this study is to evaluate the role of DWI in dif-
ferentiating benign from malignant breast lesions.2. Patients and methods
2.1. Study population
A total of 62 women (age range 18–72 years, mean 47 years)
who underwent breast MRI due to suspicious breast lesions
on mammography (BI-RADS, type 4&5) or sonomamographybenign, and malignant breast le
lesions according to
alues (n= 78)
ADC
(mea
1.46
0.92
1.62
ts.were included in this study. Purely cystic lesions (with no sig-
niﬁcant restriction within the lesion could be detected) were ex-
cluded from the study. All patients underwent subsequent core
needle or surgical biopsy.
2.2. MRI protocol
All the MRI studies were performed in a 1.5 T unit (Signa Ex-
cite HD; GE Healthcare, Milwaukee, USA), after obtaining
prior consent, with a dedicated bilateral 16-channel phased-ar-
ray breast coil, in which patient entered the magnetic bore
head ﬁrst and lied prone with both breasts freely suspended,
Previously to the diffusion-weighted sequence, conventional
and dynamic sequences were acquired.
2.3. Images acquisition
All series were acquired in oblique axial plan in which long axis
is parallel to nipple. Axial, T1-weighted fast spin-echo se-
quence (TR/TE: 783/10.6/EF,EC:1/1 35.7 kHz, FOV, 35 cm;
NEX:2.00; slice thickness, 3.0 mm; interval, 1.0 mm), sagittal,
T2-weighted fast spin-echo sequence (TR/TE, 3350/100.3/EF,
EC:1/1 31.2khz, FOV, 20 cm, NEX:3.00, slice thickness,
3.0 mm; interval, 1.0 mm). Dynamic MRI was performed by
hybrid technique using T1-weighted 3D fast spoiled gradient-
recalled echo sequence with parallel image (VIBRANT.GE
healthcare), (TR/TE: 5.2/2.5,EC:1/1 50 kHz, FOV, 33 cm;
NEX:0.71; slice thickness, 1.8 mm; interval, 10.0 mm), for 5–
7 min after administration of contrast agent (gadolinium
dimeglumin; magnivist, Schering, 1 mmol/kg) by power injec-
tor at rate of 2 ml/s, followed by a 20 ml isotonic sodium chlo-
ride ﬂush.
This technique is started by mask phase for good quality of
image, subtraction phase during which contrast agent is in-
jected at its last 15 s followed by six phases, each last from
1.20 to 1.30 min.
DWI was performed after DCE-MRI acquisition using dif-
fusion-weighted echo planer imaging (EPI) sequence with par-
allel imaging (ASSET.GE. Healthcare), (TR/TE: 3750/72.6/
EF,EC:1/1 250 kHz, FOV, 33 cm; NEX:16.00; slice thickness,
3.0 mm; interval, 1.0 mm), Diffusion gradient were applied atsions, and normal ﬁbroglandular tissue.
values
n ± SD · 10 mm2/s)
No. of lesions according to
ﬁnal histopathological results (n= 78)
± 0.48 51
± 0.23 27
± 0.27 _
Fig. 1 Forty-ﬁve year-old female patient presenting malignant
mass in the left breast (invasive ductal carcinoma): delayed
enhance-contrast axial T1-WI (A), DWI (b= 1000 s/mm2) in
axial plane (B), and apparent diffusion coefﬁcient (ADC) color
map in axial plane (C), showed morphology and contrast
enhancement of suspicious malignant lesion (arrow), the lesion
presents high signal at DWI and low signal at ADC map denoting
absence of water molecules and diffuse restriction ADC
value = 0.91 · 103 mm2/s.
Fig. 2 Twenty-four year-old female patient presented with
malignant lesion in the right breast (ductal carcinoma in situ):
delayed enhance-contrast axial T1-WI (A), DWI (b= 1000 s/
mm2) in axial plane (B), and apparent diffusion coefﬁcient (ADC)
black/white map in axial plane (C), showed morphology and
contrast enhancement of suspicious malignant lesion (arrow), it
displays hyperintense signal at DWI and hypointense signal at
ADC map denoting restriction of water ADC value = 0.89 ·
103 mm2/s.
Diffusion-weighted imaging of breast tumors 95six direction with b= 0 and 1000 mm2/s, and scanning time
was 4 min and 8 s.
2.4. Image analysis
Each lesion was assessed using the American College of Radi-
ology BI-RADS breast MRI lexicon incorporating morpho-logical and kinetic features, then the DCE-MRI&DWI were
analyzed retrospectively using a commercial software (Func-
tool; GE Healthcare, Milwaukee, USA), for image post-pro-
cessing, parametric map generation and ROI enhancement
measurement, in most cases, correlation between the initial
suspicious DCE-MRI ﬁndings and the DWI region of interest
(ROI) were performed.
96 G.K. Gouhar, E.-S.H. ZidanIn this maps, lesions that are strongly enhanced, appear
red, whereas slowly enhanced appear green, intermediate le-
sions are orange or yellow.
A ROI was deﬁned for each DEC/MRI detected lesion at
the corresponding location on the combined DWI series, The
signal enhancement ratio (SER) and apparent diffusion coefﬁ-
cient (ADC) values were automatically calculated by placing
the ROI well within the conﬁnes of the lesion including the
area of hyperintensity, when lesion was not hyperintense at
DWI, the ROI was drawn at corresponding location and size
as reﬂected on DCE-MRI. In order to achieve standardized
conditions for results analysis and avoiding data contamina-
tion by adjacent structures, two regions of interest (ROI), with
mean area of 61 mm2 (ranging from 40 to 94 mm2), were indi-
vidually placed on the DCE-MRI or ADC map at the site of
the target lesion and the signal enhancement ratio curves
(SER) as well as mean ADC was calculated, in which the scan-
ner software provides the mean value within the ROI, which
equals the ADC value (multiplied by 103).
2.5. Quantiﬁcation of enhancement
The use of ROI temporal-enhancement curves has been
strongly highlighted by proponents of dynamic MRM.
Three basic curve shapes have been described by Kuhl &
Co-investigator (16). Type I is persistently enhancing in which
gradual steady enhancement occurs over about 5 min. This has
been further classiﬁed into type Ia: slowly linearly progressive
enhancement, type Ib: slow enhancement with a late plateau
that produce a bow-like curve; type II plateau curve, and type
III washout curve.
2.6. Statistical analysis
Sensitivity and speciﬁcity for DWI in differentiating benign
from malignant breast lesions were calculated. A P va-
lue < 0.05 was considered statistically signiﬁcant.Fig. 3 Sixty year-old female patient presented by left breast
benign lesion (ﬁbroadenoma): early enhance-contrast axial T1-WI
(A), DWI (b= 1000 s/mm2) in axial plane (B), and apparent
diffusion coefﬁcient (ADC) black/white map in axial plane (C),
showed small lesion of morphology and contrast enhancement of
suspicious benign solid lesion (arrow), it displays hyperintense
signal at DWI and ADC map denoting absence of restriction.
ADC value = 1.42 · 103 mm2/s.3. Results
Seventy-eight lesions were detected in the examined 62 patients
included in this study. Fifty one lesions were benign and 27 le-
sions were malignant according to the ﬁnal histopathological
results.
According to the ADC values (Table 1) 26 lesions were
malignant (Figs. 1 and 2), and showed ADC values in the
range of (0.92 ± 0.23 · 103 mm2/s).
On DCE-MRI two lesions showed type 1 (persistent) curve,
four lesions had type 2 (plateau) curve, and 19 lesions had type
3 (washout) curve. One lesion (1/26) had malignant ADC value
and type 2 (plateau) curve, however proved to be benign lesion
according to ﬁnal histopathological results. Two lesions were
falsely diagnosed as benign ones as these lesions showed a
higher ADC values, one lesion had type 3 (washout) curve,
and the second (Fig. 4) had type 2 (plateau) curve, these 2 le-
sions proved to be malignant according to the ﬁnal results.
A total of 52 lesions showed higher ADC values than malig-
nant lesion (Table 1) and were in the range of
(1.46 ± 0.48 · 103 mm2/s) and were diagnosed as benign le-
sions (Fig. 3).On DCE-MRI 41 lesions showed type 1 (persistent) curve,
nine lesions had type 2 (plateau) curve, and three lesions had
type 3 (washout) curve.
The mean ADC values of the normal breast parenchyma
were (1.62 ± 0.27 · 103 mm2/s).
Fig. 4 Forty year-old female patient presented by large mass at left breast (cystsarcoma phylloid): early enhance-contrast axial T1-WI
(A), dynamic enhanced curve (B), DWI (b= 1000 s/mm2) in axial plane (C), and apparent diffusion coefﬁcient (ADC) color map in axial
plane (D), showed large lesion of morphology and contrast enhancement of suspicious benign lesion (curved arrow) with cystic changes
(straight arrow), however analysis of enhancement curve denotes rapid initial rinsing and a post-initial plateau curve (type II), it displays
hyperintense signal at DWI and ADC map denoting absence of restriction. ADC value = 1.27 · 103 mm2/s.
Diffusion-weighted imaging of breast tumors 97The sensitivity, and speciﬁcity for DWI in the differentiat-
ing benign and malignant breast lesions were 92.6% and
98%, respectively.
4. Discussion
DWI provides biologic information that are based on the
molecular motion of water caused by the change in the tissue
environment due to pathologic process (17). DWI is based
on the ‘‘Brownian motion’’ of the molecules. Malignant breast
lesions have higher cellularity and lower ADC values than be-
nign lesions (18). So this sequence seems to be useful in differ-
entiating benign and malignant lesions, and in monitoring the
response to therapy. Cystic areas or high mucin content within
the malignant tumor may show higher ADC values, so errone-
ously diagnosed as benign lesions (19,20). On the other hand,
highly cellular benign lesions may have low ADC values lead-
ing to erroneous diagnosis as malignant lesions (21).In this study the mean ADC value for benign breast lesions
was 1.46 ± 0.48 · 103 mm/s, and 0.92 ± 0.23 · 103 mm/s
for malignant breast lesions.
The two false negative cases for malignancy presented in
this study was due to the presence of cystic areas that were in-
cluded in the ROI on ADC map leading to false high ADC val-
ues. One false positive case for malignancy was due to the high
cellular content of the lesion, which was proved by histopa-
thological study.
These values agreed with the previous studies (22–26)
regarding the mean ADC values in differentiating benign from
malignant breast lesions.
Previous studies (12,22,23,27,9,10,28,29) showed the sensi-
tivity & speciﬁcity of DWI in the differentiation between be-
nign and malignant breast lesions were ranging from 81% to
97%, and from 80% to 100% respectively. Our study agreed
with these studies where the sensitivity & speciﬁcity were
92.6% and 98%, respectively.
98 G.K. Gouhar, E.-S.H. ZidanDWI has some limitations, it can’t recognize lesions smaller
than 1 cm, and therefore the exact localization of ROI on
ADC map is difﬁcult leading to the possibility of false sam-
pling from adjacent tissue (21,22). However, a recent study
found a low likelihood of cancer in lesions below 5 mm (30).
Another limitation is the alteration of the ADC value if cystic
or necrotic components were included in the ROI (18).
Mi et al. (23) stated in their study that, data from previous
studies showed discrepancies in the ADC values along the dif-
ferent b Values; hence they recommend that the ADC value of
breast lesions be compared to that of normal ﬁbroglandular
tissue.
In conclusion, DWI offers a useful method for differentia-
tion between benign and malignant breast lesions with high
sensitivity and speciﬁcity. The absence of contrast media in
DWI reduces the cost of the examination and acts as a prob-
lem solving sequence in patients with allergy to contrast media.
DWI is a short time screening scan that when added to the
standard MRI examination of the breast leads to an increase in
the overall accuracy of MRI, hence reducing the number of
false positive results and consequently reducing the number
of unnecessary biopsies.References
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